Extendicare Inc. (TSX:EXE)
Canada · Delayed Price · Currency is CAD | Market Cap | 3.15B +167.1% |
| Revenue (ttm) | 1.75B +18.8% |
| Net Income | 122.36M +58.6% |
| EPS | 1.37 +54.3% |
| Shares Out | 94.46M |
| PE Ratio | 24.41 |
| Forward PE | 21.61 |
| Dividend | 0.50 (1.51%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 500,048 |
| Average Volume | 330,680 |
| Open | 33.48 |
| Previous Close | 33.13 |
| Day's Range | 33.02 - 33.87 |
| 52-Week Range | 12.12 - 35.62 |
| Beta | 1.15 |
| RSI | 70.63 |
| Earnings Date | May 7, 2026 |
About Extendicare
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and ... [Read more]
Financial Performance
In 2025, Extendicare's revenue was 1.66 billion, an increase of 13.25% compared to the previous year's 1.47 billion. Earnings were 96.66 million, an increase of 28.52%.
Financial StatementsNews
Extendicare price target raised to C$39 from C$32 at TD Securities
TD Securities raised the firm’s price target on Extendicare (EXETF) to C$39 from C$32 and keeps a Buy rating on the shares.
Extendicare price target raised to C$38 from C$32 at CIBC
CIBC raised the firm’s price target on Extendicare (EXETF) to C$38 from C$32 and keeps an Outperformer rating on the shares.
Extendicare Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and AFFO growth, driven by Home Healthcare volumes and acquisitions. The CBI acquisition and new unsecured notes enhanced scale and capital flexibility, while integration and deleveraging are near-term priorities.
CUPE’s Extendicare Central Table Receives Overwhelming Mandate for Job Action if a Deal is not Reached
MARKHAM, ON. — CUPE’s Extendicare Central Bargaining table is holding strategic planning meetings in Markham this week, one month after negotiations ended with Extendicare. The eight CUPE locals from ...
CUPE's Extendicare Central Table Receives Overwhelming Mandate for Job Action if a Deal is not Reached
MARKHAM, ON.--(BUSINESS WIRE)--CUPE's Extendicare Central Bargaining table is holding strategic planning meetings in Markham this week, one month after negotiations ended with Extendicare. The eight C...
Extendicare initiated with a Buy at Desjardins
Desjardins initiated coverage of Extendicare (EXETF) with a Buy rating and C$34.50 price target The firm believes that Extendicare’s shift toward seniors care services, combined with an aging Canadian...
Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders
MARKHAM, Ontario, April 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders ...
Extendicare Transcript: AGM 2026
The meeting highlighted strong financial growth, expanded home care capacity, and ongoing investments in technology and staff development. Shareholders approved all proposals, including director elections and executive compensation, while management addressed concerns about care quality, staffing, and sector challenges.
Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 14, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE)...
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE)...
Extendicare Announces Timing of 2026 First Quarter Results and Conference Call
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter o...
Extendicare upgraded to Buy from Hold at TD Securities
TD Securities analyst Jonathan Kelcher upgraded Extendicare (EXETF) to Buy from Hold with a price target of C$32, up from C$19, after resuming coverage. The firm cites a more favorable…
Extendicare upgraded to Buy from Hold at TD Securities
TD Securities upgraded Extendicare (EXETF) to Buy from Hold with a C$32 price target
CUPE members preparing for province-wide action after negotiations stall at the Extendicare Central Table
Markham, ON--(BUSINESS WIRE)--Members of CUPE's central negotiation table are preparing for a summer of action after negotiations with Extendicare's management team stalled this week. The parties met ...
Extendicare Acquires CBI Home Health
MARKHAM, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that its wholly-owned home health care subsidiary, ParaMed Inc. (“ParaMed” o...
Extendicare Announces Proposed Changes to Board of Directors
MARKHAM, Ontario, March 18, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced that its board of directors (“Board of Directors” or “Board”) has nomi...
Extendicare Announces March 2026 Dividend of C$0.0441 per Share
MARKHAM, Ontario, March 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.0441 per common share of the Com...
Extendicare price target raised to C$30 from C$25 at RBC Capital
RBC Capital raised the firm’s price target on Extendicare (EXETF) to C$30 from C$25 and keeps an Outperform rating on the shares.
Extendicare Earnings Call Transcript: Q4 2025
Q4 and full-year results showed strong organic growth, margin expansion, and successful acquisitions, with adjusted EBITDA up 36.4% year-over-year and a 5% dividend increase. The CBI Home Health acquisition is set to add scale and synergies, while capital structure remains robust.
Extendicare Announces 2025 Fourth Quarter and Full Year Results and Dividend Increase
MARKHAM, Ontario, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2025.
Extendicare Announces February 2026 Dividend of C$0.042 per Share
MARKHAM, Ontario, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Compa...
Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call
MARKHAM, Ontario, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter o...
Extendicare Announces January 2026 Dividend of C$0.042 per Share
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Compa...
Extendicare Announces December 2025 Dividend of C$0.042 per Share
MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Compa...
Extendicare price target raised to C$22.50 from C$20 at Canaccord
Canaccord raised the firm’s price target on Extendicare (EXETF) to C$22.50 from C$20 and keeps a Buy rating on the shares.